The Path to Personalized Medicine in IBD TUESDAY, April 9, 2019 12:15pm--Hope Conference Center THE PATH TO PERSONALIZED MEDICINE IN IBD DERMOT P.B. MCGOVERN, MD, PHD, MRCP DIRECTOR, TRANSLATIONAL MEDICINE F. WIDJAJA FOUNDATION INFLAMMATORY BOWEL AND IMMUNOBIOLOGY RESEARCH INSTITUTE, CEDARS-SINAI MEDICAL CENTER PLANNER/MODERATOR: Ora Gordon, MD, MS; Regional Medical Director, Center for Clinical Genetics & Genomics; Medical Director, Integrative Medicine, Roy and Patricia Disney Family Cancer Center, PSJMC FACULTY/PLANNER DISCLOSURES: It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Gordon states she has no financial arrangements with any commercial company to disclose. Dr. McGovern discloses he is a consultant for Precision IBD, Gilead, Janssen, Bridge Therapeutics, Qu Biologics, and Pfizer, and has received grant support from Janssen and Second Genome. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation. Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at www.providencecme.org. Click Here For Learning Objectives Release Date: 5-15-19 Review Date: 5/22 Termination Date: This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.

4/9/2019 Dermot McGovern, MD. Presenter Hope Conference Center

Are you sure? If you wish to continue without passing the post test no credit will be given at this time. You may retake the test at any time. Clicking (Yes, I will retest later), clicking (No, I will retest now)